Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
The Methodist Hospital Research Institute
University of Alabama at Birmingham
Boehringer Ingelheim
Eli Lilly and Company
Eli Lilly and Company
Tomsk National Research Medical Center of the Russian Academy of Sciences
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC
Incyte Corporation
M.D. Anderson Cancer Center
Ambrx, Inc.
Daiichi Sankyo
UMC Utrecht
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Aarhus University Hospital
National Cancer Institute (NCI)
AstraZeneca
AstraZeneca
M.D. Anderson Cancer Center
EMD Serono
Pfizer
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Genentech, Inc.
Celcuity Inc
University of Oklahoma
Werewolf Therapeutics, Inc.
Novartis
ModernaTX, Inc.
AstraZeneca
Wake Forest University Health Sciences
Gilead Sciences
EMD Serono
AstraZeneca
Massachusetts General Hospital
SWOG Cancer Research Network
Eli Lilly and Company
University of Rochester
Martini-Klinik am UKE GmbH